Crinetics Pharmaceuticals CRNX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's cash ratio?
- Crinetics Pharmaceuticals (CRNX) reported cash ratio of 1.6× in Q1 2026.
- How has Crinetics Pharmaceuticals's cash ratio changed year-over-year?
- Crinetics Pharmaceuticals's cash ratio decreased by 3.2% year-over-year, from 1.7× to 1.6×.
- What is the long-term trend for Crinetics Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's cash ratio has grown at a -32.9% compound annual growth rate (CAGR), from 8.9× to 1.2×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.